iDna Genetics Limited - Accounts to registrar (filleted) - small 18.2

iDna Genetics Limited - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v19.3.2.199 05061695 director 1.4.18 31.3.19 31.3.19 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure050616952018-03-31050616952019-03-31050616952018-04-012019-03-31050616952017-03-31050616952017-04-012018-03-31050616952018-03-3105061695ns14:PoundSterling2018-04-012019-03-3105061695ns10:Director12018-04-012019-03-3105061695ns10:PrivateLimitedCompanyLtd2018-04-012019-03-3105061695ns10:SmallEntities2018-04-012019-03-3105061695ns10:AuditExempt-NoAccountantsReport2018-04-012019-03-3105061695ns10:SmallCompaniesRegimeForDirectorsReport2018-04-012019-03-3105061695ns10:SmallCompaniesRegimeForAccounts2018-04-012019-03-3105061695ns10:FullAccounts2018-04-012019-03-310506169512018-04-012019-03-3105061695ns10:CompanySecretary12018-04-012019-03-3105061695ns10:RegisteredOffice2018-04-012019-03-3105061695ns5:CurrentFinancialInstruments2019-03-3105061695ns5:CurrentFinancialInstruments2018-03-3105061695ns5:Non-currentFinancialInstruments2019-03-3105061695ns5:Non-currentFinancialInstruments2018-03-3105061695ns5:ShareCapital2019-03-3105061695ns5:ShareCapital2018-03-3105061695ns5:RetainedEarningsAccumulatedLosses2019-03-3105061695ns5:RetainedEarningsAccumulatedLosses2018-03-3105061695ns5:NetGoodwill2018-04-012019-03-3105061695ns5:IntangibleAssetsOtherThanGoodwill2018-04-012019-03-3105061695ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2018-04-012019-03-3105061695ns5:PlantMachinery2018-04-012019-03-3105061695ns5:FurnitureFittings2018-04-012019-03-3105061695ns5:ComputerEquipment2018-04-012019-03-3105061695ns5:NetGoodwill2018-03-3105061695ns5:IntangibleAssetsOtherThanGoodwill2018-03-3105061695ns5:NetGoodwill2019-03-3105061695ns5:IntangibleAssetsOtherThanGoodwill2019-03-3105061695ns5:NetGoodwill2018-03-3105061695ns5:IntangibleAssetsOtherThanGoodwill2018-03-3105061695ns5:PlantMachinery2018-03-3105061695ns5:PlantMachinery2019-03-3105061695ns5:PlantMachinery2018-03-3105061695ns5:CurrentFinancialInstrumentsns5:WithinOneYear2019-03-3105061695ns5:CurrentFinancialInstrumentsns5:WithinOneYear2018-03-3105061695ns5:BetweenTwoFiveYearsns5:Non-currentFinancialInstruments2019-03-3105061695ns5:BetweenTwoFiveYearsns5:Non-currentFinancialInstruments2018-03-3105061695ns5:RetainedEarningsAccumulatedLosses2018-03-3105061695ns5:RetainedEarningsAccumulatedLosses2018-04-012019-03-31


REGISTERED NUMBER: 05061695















Unaudited Financial Statements For The Year Ended 31st March 2019

for

iDna Genetics Limited

iDna Genetics Limited (Registered number: 05061695)






Contents of the Financial Statements
For The Year Ended 31st March 2019




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


iDna Genetics Limited

Company Information
For The Year Ended 31st March 2019







DIRECTOR: Dr T Haizel





SECRETARY:





REGISTERED OFFICE: Centrum Norwich Research Park
Colney Lane
Colney
Norwich
NR4 7UG





REGISTERED NUMBER: 05061695





ACCOUNTANTS: Aston Shaw Ltd
The Union Building
51-59 Rose Lane
Norwich
Norfolk
NR1 1BY

iDna Genetics Limited (Registered number: 05061695)

Balance Sheet
31st March 2019

31/3/19 31/3/18
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 117,670 147,522
Tangible assets 5 125,950 136,425
243,620 283,947

CURRENT ASSETS
Stocks 26,618 28,419
Debtors 6 1,152,618 1,034,407
Cash at bank and in hand 100,619 112,327
1,279,855 1,175,153
CREDITORS
Amounts falling due within one year 7 728,702 625,104
NET CURRENT ASSETS 551,153 550,049
TOTAL ASSETS LESS CURRENT
LIABILITIES

794,773

833,996

CREDITORS
Amounts falling due after more than one
year

8

199,825

329,067
NET ASSETS 594,948 504,929

CAPITAL AND RESERVES
Called up share capital 298,927 298,926
Retained earnings 10 296,021 206,003
594,948 504,929

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st March 2019.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st March 2019 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end
of each financial year and of its profit or loss for each financial year in accordance with the requirements of
Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to
financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director on 30th January 2020 and were signed by:





Dr T Haizel - Director


iDna Genetics Limited (Registered number: 05061695)

Notes to the Financial Statements
For The Year Ended 31st March 2019

1. STATUTORY INFORMATION

iDna Genetics Limited is a private company, limited by shares , registered in Not specified/Other. The company's
registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates,
value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2019 is not being amortised.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost
less any accumulated amortisation and any accumulated impairment losses.

Development costs are being amortised evenly over their estimated useful life of five years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 20% straight line
Fixtures and fittings - 20% straight line
Computer equipment - 33% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and
slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to
the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or
substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the
balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from
those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws
that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal
of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they
will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the
lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension
scheme are charged to profit or loss in the period to which they relate.

iDna Genetics Limited (Registered number: 05061695)

Notes to the Financial Statements - continued
For The Year Ended 31st March 2019

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 27 (2018 - 23 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
Goodwill assets Totals
£    £    £   
COST
At 1st April 2018
and 31st March 2019 28,113 149,261 177,374
AMORTISATION
At 1st April 2018 - 29,852 29,852
Charge for year - 29,852 29,852
At 31st March 2019 - 59,704 59,704
NET BOOK VALUE
At 31st March 2019 28,113 89,557 117,670
At 31st March 2018 28,113 119,409 147,522

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1st April 2018 307,060
Additions 2,231
At 31st March 2019 309,291
DEPRECIATION
At 1st April 2018 170,635
Charge for year 12,706
At 31st March 2019 183,341
NET BOOK VALUE
At 31st March 2019 125,950
At 31st March 2018 136,425

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31/3/19 31/3/18
£    £   
Trade debtors 450,519 362,068
Amounts owed by group undertak 602,161 587,929
Other debtors 3,500 -
Tax 36,100 36,100
Accrued income 9,657 9,657
Prepayments 50,681 38,653
1,152,618 1,034,407

iDna Genetics Limited (Registered number: 05061695)

Notes to the Financial Statements - continued
For The Year Ended 31st March 2019

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31/3/19 31/3/18
£    £   
Bank loans and overdrafts (see note 9) 25,035 24,759
Other loans (see note 9) 182,914 158,381
Trade creditors 93,311 112,010
Social security and other taxes 12,132 15,636
Pension 4,585 4,556
VAT 38,572 32,503
Other creditors 55,822 32,000
Factoring account 215,849 172,207
Accrued expenses 100,482 73,052
728,702 625,104

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
31/3/19 31/3/18
£    £   
Other loans (see note 9) 199,825 329,067

9. LOANS

An analysis of the maturity of loans is given below:

31/3/19 31/3/18
£    £   
Amounts falling due within one year or on demand:
Bank overdrafts 25,035 24,759
Other loan - less than 1 year 182,914 158,381
207,949 183,140

Amounts falling due between two and five years:
Other loans - 2-5 years 199,825 329,067

10. RESERVES
Retained
earnings
£   

At 1st April 2018 206,003
Profit for the year 125,788
Dividends (35,770 )
At 31st March 2019 296,021

11. ULTIMATE CONTROLLING PARTY

The controlling party is Dr T Haizel.